drugset

drugset / Trial / NCT00154804

CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer

NCT00154804 ↗

Phase 2 Completed 40 enrolled National Taiwan University Hospital

Non-randomizedSingle-groupOpen-labelTreatment

Summary

CCRT with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.

Timeline

Start: 2001-08
Primary completion: —
Completion: 2004-04

Publications

Guo JC, Huang TC, Lin CC, Hsieh MS, Chang CH, Huang PM, Lee JM, Hsu FM, Chia-Hsien Cheng J, Wang HP, Yeh KH, Cheng AL, Hsu CH. Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma. J Thorac Oncol. 2015 Oct;10(10):1481-9. doi: 10.1097/JTO.0000000000000651.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cisplatin	Other / unclassified	—	—
Subject	Paclitaxel	Small molecule	—	—

Indications